Palbociclib Dihydrochloride|CAS 571189-11-2|DC Chemicals

Cas No.:	571189-11-2
Chemical Name:	Palbociclib hydrochloride
Synonyms:	6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one,dihydrochloride;PD 0332991 HYDROCHLORIDE;Palbociclib 2HCl;6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8h-pyrido[2,3-d]pyrimidin-7-one hydrochloride;C24H29N7O2.2HCl;SYN1180;BCP22592;BCP9001061;6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one;dihydrochloride;6-Acetyl-8-cyclopentyl-5-methyl;Palbociclib hydrochloride;PALBOCICLIB DIHYDROCHLORIDE;PALBOCICLIB DIHYDROCHLORIDE;PALBOCICLIB DIHYDROCHLORIDE;PALBOCICLIB DIHYDROCHLORIDE;PALBOCICLIB DIHYDROCHLORIDE;PALBOCICLIB DIHYDROCHLORIDE;PALBOCICLIB DIHYDROCHLORIDE;PD 0332991 hydrochloride;PD 0332991 hydrochloride;PD 0332991 hydrochloride;PD 0332991 hydrochloride;PD 0332991 hydrochloride;PD 0332991 hydrochloride;PD 0332991 hydrochloride;E98902;E98902;E98902;E98902;E98902;E98902;E98902;571189-11-2;571189-11-2;571189-11-2;571189-11-2;571189-11-2;571189-11-2;571189-11-2;Palbociclib dihydrochloride;PD 0332991 2HCl;PD0332991 2HCl;PD-0332991 2HCl;Palbociclib dihydrochloride;PD 0332991 2HCl;PD0332991 2HCl;PD-0332991 2HCl;Palbociclib dihydrochloride;PD 0332991 2HCl;PD0332991 2HCl;PD-0332991 2HCl;Palbociclib dihydrochloride;PD 0332991 2HCl;PD0332991 2HCl;PD-0332991 2HCl;Palbociclib dihydrochloride;PD 0332991 2HCl;PD0332991 2HCl;PD-0332991 2HCl;Palbociclib dihydrochloride;PD 0332991 2HCl;PD0332991 2HCl;PD-0332991 2HCl;Palbociclib dihydrochloride;PD 0332991 2HCl;PD0332991 2HCl;PD-0332991 2HCl;1831842-69-3;1831842-69-3;1831842-69-3;1831842-69-3;1831842-69-3;1831842-69-3;1831842-69-3;AS-16315;AS-16315;AS-16315;AS-16315;AS-16315;AS-16315;Palbociclib (dihydrochloride);AS-16315;Palbociclib (dihydrochloride);Palbociclib (dihydrochloride);Palbociclib (dihydrochloride);Palbociclib (dihydrochloride);Palbociclib (dihydrochloride);CS-0012539;Palbociclib (dihydrochloride);CS-0012539;CS-0012539;CS-0012539;CS-0012539;CS-0012539;PD0332991 hydrochloride;PD0332991 hydrochloride;CS-0012539;PD0332991 hydrochloride;PD-0332991 hydrochloride;PD0332991 hydrochloride;PD0332991 hydrochloride;PD0332991 hydrochloride;PD-0332991 hydrochloride;PD0332991 hydrochloride;PD-0332991 hydrochloride;AKOS025395141;PD-0332991 hydrochloride;PD-0332991 hydrochloride;PD-0332991 hydrochloride;AKOS025395141;PD-0332991 hydrochloride;AKOS025395141;6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride;AKOS025395141;AKOS025395141;6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride;AKOS025395141;AKOS025395141;6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride;6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride;...
SMILES:	Cl[H].Cl[H].O=C1C(C(C([H])([H])[H])=O)=C(C([H])([H])[H])C2=C([H])N=C(N([H])C3C([H])=C([H])C(=C([H])N=3)N3C([H])([H])C([H])([H])N([H])C([H])([H])C3([H])[H])N=C2N1C1([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]
Formula:	C₂₄H₃₁Cl₂N₇O₂
M.Wt:	520.4546
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

MSDS

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.